用同位素技术测量哺乳期母牛的反保护氨酸的生物可用性,利用率和分泌率
L R Rebelo1, C Lee1
1Department of Animal Sciences, The Ohio State University, Wooster, OH 44691, USA.
Animal : an international journal of animal bioscience
|April 4, 2024
概括
在奶牛中补充流血保护型氨酸 (RP-Lys) 的生物可用性为68%. 这种素被用于牛奶蛋白质合成,并且在氧化后在尿液中分泌.
科学领域:
- 动物营养 动物营养
- 动物生理学 动物生理学
- 氨基酸新陈代谢 氨基酸新陈代谢
背景情况:
- 补充与反保护氨基酸 (AAs) 的饮食对于高效的畜牧业生产至关重要.
- 了解反蛋白保护的AAs的生物可用性和代谢对于成本有效的应用至关重要.
研究的目的:
- 为了确定乳母奶牛的生物可用性,吸收,利用和排泄的反保护氨酸 (RP-Lys).
- 为了阐明从RP-Lys补充中获得的被吸收的氨酸的代谢命运.
主要方法:
- 一个4x4拉丁方形设计,有四头牛.
- 将L-氨酸和15N-氨酸输入腹腔以标记氨基酸池.
- 牛奶,尿液和便的总收集用于定量分析.
- 使用15N丰富的氨酸流的建模,以计算生物可用性和代谢.
主要成果:
- 增加氨酸供应增加了牛奶产量,但也增加了尿道分泌.
- 从RP-Lys中吸收的氨酸估计为28g/d,导致总吸收的氨酸为136g/d.
- 确定RP-Lys的生物利用率为68%.
结论:
- 乳液保护素 (RP-Lys) 在奶牛中具有68%的生物可用性.
- 由RP-Lys供应的氨酸用于牛奶蛋白质合成 (48%),并在氧化后通过尿液 (20%) 排出.
相关概念视频
Methods for Studying Drug Absorption: In vitro
839
In vitro experiments are crucial for understanding the transport and absorption of drugs through biological materials. These studies employ varied methods such as the diffusion cell method, the everted sac technique, and the everted ring technique.
The diffusion cell method uses a two-compartment cell, including a donor compartment with the drug solution, which simulates the environment where the drug is applied, and a receptor compartment with a buffer solution, which simulates the environment...
The diffusion cell method uses a two-compartment cell, including a donor compartment with the drug solution, which simulates the environment where the drug is applied, and a receptor compartment with a buffer solution, which simulates the environment...
839
Methods for Studying Drug Absorption: In situ
886
In situ experiments, such as the Doluisio method and Single-Pass Perfusion technique, provide critical insights into drug uptake by simulating in vivo conditions for drug absorption.
The Doluisio method involves perfusing a prepared segment of a rat's small intestine with a solution of radiolabeled drug and a non-absorbable marker. This helps to differentiate between absorbed and non-absorbed drug concentrations. The intestinal segment is connected at both ends using tubing and syringes,...
The Doluisio method involves perfusing a prepared segment of a rat's small intestine with a solution of radiolabeled drug and a non-absorbable marker. This helps to differentiate between absorbed and non-absorbed drug concentrations. The intestinal segment is connected at both ends using tubing and syringes,...
886
Bioavailability Study Design: Absolute Versus Relative Bioavailability
646
Bioavailability is a crucial pharmacokinetic parameter that quantifies the proportion of an administered drug that reaches the systemic circulation and is available for therapeutic action. Regulatory agencies mandate the assessment of bioavailability, typically measured as the area under the drug plasma concentration-versus-time curve (AUC), to ensure the efficacy and safety of pharmaceutical products. These evaluations are categorized as absolute and relative bioavailability studies.Absolute...
646
Measurement of Bioavailability: Pharmacokinetic Methods
513
Pharmacokinetics is a vital branch of pharmacology that examines how drugs are absorbed, distributed, metabolized, and excreted by the body. Two key methodologies in pharmacokinetics are plasma drug concentration studies and urinary drug excretion analyses, both of which provide critical insights into a drug's therapeutic efficacy and bioavailability.Plasma Drug Concentration-Time StudiesPlasma drug concentration-time studies involve analyzing blood samples at specific intervals to quantify...
513
Measurement of Bioavailability: Pharmacodynamic Methods
1.0K
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
1.0K
Modified-Release Drug Delivery Systems: Bioavailability
170
Modified-release (MR) dosage forms are designed to extend drug release over time, thereby maintaining stable plasma concentrations and reducing dosing frequency. However, their bioavailability is typically below 100% due to incomplete drug release and presystemic metabolism, and limitations in drug permeability across the gastrointestinal epithelium, all of which can restrict the fraction of the drug reaching systemic circulation. Consequently, studying the in vivo bioavailability of MR...
170


